GlaxoSmithKline and Daniel E. Troy to Receive CPR Institute’s 2011 Corporate Leadership Award


Honorees Recognized for Leadership and Commitment to the
Principles of Dispute Management and Resolution

New York, NY, November 2, 2011 – The International Institute for Conflict Prevention & Resolution (CPR Institute), a nonprofit alliance of global corporations, law firms, scholars, and public institutions dedicated to the principles of commercial conflict prevention, announces the recipients of the organization’s 2011 Corporate Leadership Award.  This year, the CPR Institute honors GlaxoSmithKline (GSK) and Daniel E. Troy, its Senior Vice President and General Counsel, for dedication to the field of alternative dispute resolution (ADR).  The award will be presented tonight in New York City.

Each year, the CPR Institute honors a corporation and its general counsel for demonstrating leadership and commitment to the principles of conflict management and resolution, especially those that have institutionalized ADR principles into their corporate and industry culture. Previous honorees have included:
  • Amgen Inc. and its SVP, General Counsel & Secretary David W. Scott (2010)
  • FMC Technologies Inc. and its SVP, General Counsel & Secretary
    Jeffrey W. Carr (2010)
  • DuPont Company and its SVP & General Counsel Thomas L. Sager (2009)
  • Pfizer Inc. and its SVP & General Counsel Amy W. Schulman (2009)
  • Microsoft Corporation and its SVP & General Counsel Brad Smith (2008)
“GlaxoSmithKline has been an industry leader in bringing innovative alternative dispute resolution approaches to drug industry disputes,” said Kathleen A. Bryan, President and CEO of the CPR Institute.  “Under the outstanding leadership of Dan Troy, GSK has integrated ADR into its operations by devising a systematic approach to early case assessment and by establishing a commitment to ADR education for both its in-house legal team and its outside counsel. GSK has set a successful benchmark against which all companies’ legal departments should be measured.”

GSK has deep roots as an advocate of alternative dispute resolution. The company joined the CPR Institute and signed the CPR Corporate Policy Statement on Alternatives to Litigation© in 1988.

As head of GSK’s legal team, Dan Troy has demonstrated leadership and dedication to conflict management principles throughout his legal career in private practice, public service and as corporate counsel. Under his leadership, GSK is currently spearheading an effort to develop meaningful corporate data about the efficiency and financial impact of alternative methods of resolving disputes. Such data is integral to developing understanding, across industries and companies, of the tangible and quantifiable benefits of integrating ADR systems and standards as a means to resolve disputes.

“I am truly honored to receive this award on behalf of GSK and our legal team,” said Dan Troy, Senior Vice President and General Counsel, GlaxoSmithKline. “The CPR Corporate Leadership Award is a testament to our success in finding new and effective ways to approach litigation matters. By identifying potential disputes before they happen, and by resolving litigation creatively, we are continuing to dramatically reduce our litigation risk.  Our success in ADR is a credit to my talented and dedicated colleagues in the Legal department at GSK, and to the outside counsel that support us.”

The 2011 Corporate Leadership Award will be presented at a black tie dinner at New York’s Cipriani 42nd Street.  Jonathan P. Graham, Senior Vice President and General Counsel of Danaher Corporation will serve as this year’s Master of Ceremonies. The event will draw in excess of 500 attendees representing the top corporations, law firms, scholars, and public institutions in the country.  The major corporate sponsors of this year’s Corporate Leadership Awards Dinner include Ballard Spahr LLP, General Electric, DuPont Company, Fulbright & Jaworski LLP, King & Spalding, Pepper Hamilton LLP, Phillips Lytle LLP, Sidley Austin LLP, Williams & Connolly LLP, Danaher Corporation, Debevoise & Plimpton LLP, Greenberg Traurig LLP, Reed Smith LLP, and Ropes & Gray LLP.

The funds raised by the Corporate Leadership Award Dinner support the CPR Institute’s educational, research and public policy programs.  For more information about the Corporate Leadership Award, visit here.

About GlaxoSmithKline
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information go to us.gsk.com, follow us on twitter.com/GSKUS or visit our blog (www.morethanmedicine.us.gsk.com/blog/).

About Daniel E. Troy

Daniel E. Troy joined GlaxoSmithKline as Senior Vice President, General Counsel and a member of the Corporate Executive Team in September 2008. He was previously a Partner at the Washington law firm Sidley Austin LLP, where he represented mainly pharmaceutical companies and trade associations on matters related to the U.S. Food and Drug Administration (FDA) and government regulations. He also served as Chief Counsel for the FDA, where he acted as a primary liaison to the White House and the U.S. Department of Health and Human Services.

About the CPR Institute
As a think tank and educational not-for-profit organization, the CPR Institute provides thought leadership and innovation as the global resource for conflict management and resolution of complex business-related disputes.  Our wealth of intellectual property and published material has educated and motivated General Counsel and their law firms around the world toward an increased reliance on alternative forms of dispute resolution rather than litigation. CPR Institute’s membership is comprised of general counsel and senior lawyers of Fortune 1,000 organizations, partners in the top law firms around the world, as well as leading judges, government officials, neutrals, and academicians. Our proprietary panel of esteemed arbitrators and mediators has provided resolutions in thousands of cases, with billions of dollars at issue, worldwide. For more information, please visit here.

Download a PDF of this Press Release here.